-
This week the team looks at the prospects for Convex’s new capital raise as well as the CEO transition at PartnerRe. -
This week the team looks at the final throes of lawsuit activity connected to Irma claims and new entries into the A&H sector.
-
This week the team looks at the serial underperformance of Bermudian syndicates at Lloyd’s and dissects the Q2 pre-announcements of Covid-19 losses from US insurers.
-
The industry can avert costly conflict by showing it understands the challenges facing policyholders.
-
A string of companies pre-announced Covid-19 losses yesterday, with a number posting only modest reserves.
-
This week the team looks at the consequences of Lemonade's highly successful IPO and the implications for the InsurTech's prospects.
-
The stratospheric rise of Lemonade’s share price in its opening days raises the question of whether other InsurTechs will now rush to list on the public markets.
-
-
Many questions abound concerning the business’ long-term viability.
-
Over the last decade, a big three with a much higher percentage market share than its counterpart in the US retail market has emerged.
-
The Black Lives Matter movement has created a unique window of opportunity for the (re)insurance industry to tackle structural racism.
-
Just a day after we wrote, "the board is the problem",that problem seemed to partially resolve itself, with Argo announcing the five long-tenured directors targeted for replacement by activist hedge fund Voce would be retiring at the firm’s 2020 AGM, including chairman Gary Woods.
Most Recent
